Feedback

Prof. Gaikwad Anil Bhanudas

Professor, Department of Pharmacy,
BITS Pilani, Pilani Campus

Pharmacology
Department of Pharmacy, Birla Institute of Technology & Science, Pilani- 333031, Rajasthan. India.

Sponsored Projects

 

Projects Ongoing

S.No Title of the project Funding agency Principal Investigator /Co-investigator Type of project
Amount (Lakhs)
1 Interdisciplinary life science programme for advanced research and education in epigenetics and genome editing DBT Co-investigator BUILDER 975
2 Novel pharmacological interventions against chronic kidney disease using clinically approved Inodilators, ET-1A antagonists, and Bisphosphonates: drug repurposing approach SERB Principal Investigator EMEQ 36.12
3 Design, synthesis, and evaluation of novel dual inhibitors of angiotensin-II type 1 receptor and neprilysin for the treatment of diabetic cardiomyopathy SERB Co-investigator CRG 33.02
4 Pharmacological intervention using α-Klotho with AT1 receptor blocker and sodium-glucose co-transporter 2 (SGLT-2) inhibitor against diabetic kidney disease SERB Principal Investigator CRG 38.62
5 Design, synthesis, and evaluation of novel dual inhibitors of dipeptidyl peptidase 4 (DPPIV) and neprilysin for the treatment of diabetes  ICMR Co-investigator IIRP 41.12

 

Projects Completed

S.No    Title of the project Funding agency Principal Investigator /Co-investigator Type of project Amount (Lakhs)

Identification and characterization of novel long non-coding RNAs in AKI-CKD transition using CRISPR/Cas9-based epigenome editing: revealing the potential of long non-coding RNAs as a biomarker and therapeutic strategy   ICMR  Principal Investigator  EMR 49.85
 2 Klotho regulation as a novel therapeutic strategy against acute kidney injury-diabetes comorbidity: Impact of epigenetic driven and epigenetic independent reactivation of endogenous Klotho expression SERB Principal Investigator EMEQ 50.33
3
To study the role of hyperglycemia on the progression of acute kidney injury
SERB Principal Investigator Early Carrier Research Award 47.18
4 Understanding hyperglycemia induced alterations in non-coding RNA expression pattern and post translational histone protein modifications contributing to drug resistance and progression of pancreatic cancer DST-SERB Co-investigator EMR 40.32
5
Peptide decorated pH sensitive nanoconjugate hybrid micelles for codelivery of temozolamide and an autophagy inducer, rapamycin for treatment of glioblastoma multiforme
DBT Co-investigator Nanobiotechnology 41.94
6
Alternate day fasting resembles recurrent insulin-induced hypoglycemia model in rat
SERB Mentor NPDF 19.20
7 Role of histone ubiquitination & angiotensin converting enzyme 2 in the development of renal fibrosis under type I diabetic condition CSIR, Govt of India Principal Investigator EMR
14.86
8 Effect of esculetin on the development of type II diabetic nephropathy BITS Principal Investigator Research Initiation Grant  2.00
9 Effect of esculetin on angiotensin II in rat thoracic aorta under hyperglycaemic and hyperinsulinaemic conditions UGC, Govt of India Principal Investigator Major Research Proposal 13.43
10 Understanding the epigenetic regulation in modulating inflammatory response mediated by NF-kB through AT1 or AT2 receptor in type II diabetic nephropathy DST-SERB Principal Investigator Fast Track for Young Scientist 22.21
11 Esculetin a therapeutic intervention targeted at cardio-renal syndrome in type 2 diabetes DST-SERB Principal Investigator Empowerment and Equity Opportunities for Excellence in Science 39.66